These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17205227)

  • 1. Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study.
    Padua L; Aprile I; Cavallaro T; Commodari I; La Torre G; Pareyson D; Quattrone A; Rizzuto N; Vita G; Tonali P; Schenone A;
    Neurol Sci; 2006 Dec; 27(6):417-23. PubMed ID: 17205227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings.
    Padua L; Cavallaro T; Pareyson D; Quattrone A; Vita G; Schenone A;
    Neurol Sci; 2008 Jun; 29(3):193-4. PubMed ID: 18612771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study.
    Padua L; Aprile I; Cavallaro T; Commodari I; Pareyson D; Quattrone A; Rizzuto N; Vita G; Tonali P; Schenone A;
    Neurol Sci; 2008 Jun; 29(3):157-62. PubMed ID: 18612763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of CMT1A including QoL: a 2-year prospective study.
    Padua L; Pareyson D; Aprile I; Cavallaro T; Quattrone A; Rizzuto N; Vita G; Tonali P; Schenone A
    Neuromuscul Disord; 2008 Mar; 18(3):199-203. PubMed ID: 18242090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A.
    Padua L; Shy ME; Aprile I; Cavallaro T; Pareyson D; Quattrone A; Rizzuto N; Vita G; Tonali P; Schenone A
    J Peripher Nerv Syst; 2008 Mar; 13(1):64-70. PubMed ID: 18346232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Italian version of the Charcot-Marie-Tooth Health Index.
    Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D;
    J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that influence health-related quality of life in Australian adults with Charcot-Marie-Tooth disease.
    Redmond AC; Burns J; Ouvrier RA
    Neuromuscul Disord; 2008 Aug; 18(8):619-25. PubMed ID: 18656353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual functioning in women with mild and severe symptoms of Charcot-Marie-Tooth disease.
    Gargiulo P; Vinci P; Navarro-Cremades F; Rellini AH
    J Sex Med; 2013 Jul; 10(7):1800-6. PubMed ID: 23534937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of life.
    Padua L; Pazzaglia C; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G;
    Eur J Neurol; 2016 Aug; 23(8):1343-50. PubMed ID: 27160471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure.
    Ramchandren S; Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Estilow T; Shy ME;
    Ann Neurol; 2021 Feb; 89(2):369-379. PubMed ID: 33222249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in patients with Charcot-Marie-Tooth disease.
    Vinci P; Serrao M; Millul A; Deidda A; De Santis F; Capici S; Martini D; Pierelli F; Santilli V
    Neurology; 2005 Sep; 65(6):922-4. PubMed ID: 16186535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Italian version of the pediatric CMT quality of life outcome measure.
    Moroni I; Danti FR; Pareyson D; Pagliano E; Piscosquito G; Foscan M; Marchi A; Ardissone A; Genitrini S; Wu TT; Shy ME; Ramchandren S
    J Peripher Nerv Syst; 2022 Jun; 27(2):127-130. PubMed ID: 35416371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of focal mechanic vibration treatment on balance in Charcot-Marie-Tooth 1A disease: a pilot study.
    Pazzaglia C; Camerota F; Germanotta M; Di Sipio E; Celletti C; Padua L
    J Neurol; 2016 Jul; 263(7):1434-41. PubMed ID: 27177999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of Charcot-Marie-Tooth 2: 2-year follow-up of muscle strength, walking ability and quality of life.
    Padua L; Pareyson D; Aprile I; Cavallaro T; Quattrone DA; Rizzuto N; Vita G; Tonali P; Schenone A
    Neurol Sci; 2010 Apr; 31(2):175-8. PubMed ID: 20016922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical spectrum and gender differences in a large cohort of Charcot-Marie-Tooth type 1A patients.
    Colomban C; Micallef J; Lefebvre MN; Dubourg O; Gonnaud PM; Stojkovic T; Jouve E; Blin O; Pouget J; Attarian S
    J Neurol Sci; 2014 Jan; 336(1-2):155-60. PubMed ID: 24246498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between physical performance and quality of life in Charcot-Marie-Tooth disease: a pilot study.
    Roberts-Clarke D; Fornusek C; Saigal N; Halaki M; Burns J; Nicholson G; Fiatarone Singh M; Hackett D
    J Peripher Nerv Syst; 2016 Dec; 21(4):357-364. PubMed ID: 27699915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological distress in patients with Charcot-Marie-Tooth disease.
    Vinci P; Gargiulo P; Panunzi M; Baldini L
    Eur J Phys Rehabil Med; 2009 Sep; 45(3):385-9. PubMed ID: 19182736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the parent-proxy pediatric Charcot-Marie-Tooth disease quality of life outcome measure.
    Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Muntoni F; Estilow T; Shy ME; Ramchandren S;
    J Peripher Nerv Syst; 2023 Jun; 28(2):237-251. PubMed ID: 36748295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pain in pediatric inherited neuropathies.
    Ramchandren S; Jaiswal M; Feldman E; Shy M
    Neurology; 2014 Mar; 82(9):793-7. PubMed ID: 24477108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.
    Verhamme C; van Schaik IN; Koelman JH; de Haan RJ; de Visser M
    Brain; 2009 Dec; 132(Pt 12):3252-62. PubMed ID: 19843647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.